Drug
Spiramycin clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 1
- first study started
- 2010
How studies write it
Studies that test it under each name
Name
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 3
- 1
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 1
Rhone-Poulenc Rorer (2) · Assistance Publique - Hôpitaux de Paris (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Spiramycin is read from its arms, and is right about nine times in ten.
Testing it · 3
- Prevention of Congenital Toxoplasmosis With Pyrimethamine + Sulfadiazine Versus Spiramycine During PregnancyCompletedPhase 3Assistance Publique - Hôpitaux de ParisNCT01189448Written as Spiramycine
- A Study of Spiramycin in the Treatment of Patients With AIDS-Related DiarrheaCompletedPhase 1Rhone-Poulenc RorerNCT00000980Written as Spiramycin
- Open-Label "Compassionate" Use Study of Spiramycin for the Treatment of Diarrhea Due to Chronic Cryptosporidiosis in Immunocompromised PatientsCompletedNot applicableRhone-Poulenc RorerNCT00002062Written as Spiramycin
Given in every arm · 1 — Spiramycin is usual care beside what is tested
Codes
What other systems call Spiramycin · ClinicalTrials.gg INT008475
- MeSH (NLM) D015572SpiramycinConfirmed ClinicalTrials.gov, Wikidata
- UNII (FDA) 71ODY0V87HSPIRAMYCINConfirmed FDA, Wikidata
- RxNorm 9991Confirmed FDA, Wikidata
- Wikidata Q422265spiramycinConfirmed FDA, Wikidata
- NCI Thesaurus C839SpiramycinOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D015572 | Spiramycin | Confirmed ClinicalTrials.gov, Wikidata |
| UNII (FDA) | 71ODY0V87H | SPIRAMYCIN | Confirmed FDA, Wikidata |
| RxNorm | 9991 | — | Confirmed FDA, Wikidata |
| Wikidata | Q422265 | spiramycin | Confirmed FDA, Wikidata |
| NCI Thesaurus | C839 | Spiramycin | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.